Who designs incentive schemes for pharmaceutical sales reps in South Africa?
We design and run incentive schemes for pharmaceutical sales teams in South Africa. Targets, payment curve and incentive policy are built as one system, then operated live every week. In one anonymised engagement, five reps had disengaged; we restructured the scheme mid-year around milestone resets so one bad quarter no longer wrote off the year.
How is an incentive scheme designed and run?
We design the target, the payment curve and the incentive policy as one system, then operate the scheme live every week. Target Setting and Incentive Design builds each territory’s target bottom-up from real transaction history. We test the payment curve against that target, designing out a steep curve on an impossible target and a generous curve on an easy one. Schemes are quota-based and conditional, segmented by performer tier where the design calls for it, with deliberate reward timing.
What does it yield?
It yields a scheme we can correct mid-flight, because we run it live every week. A rep who drifts off target is spotted within days, not at year-end.
In one anonymised engagement, five reps had effectively disengaged. A mid-year restructure around milestone resets brought three of them back to within 15 percent of a fair, rebuilt target, and two posted their strongest fourth quarter in years.
A published field experiment on sales-force pay, Incentives versus Reciprocity in the Journal of Marketing Research, found that quota-based conditional incentives lifted sales by about 24 percent across every performer tier. That is a published result, not a Herbst result. Both are described on the service page.
What do we need from you?
We need your current targets, payment curve and incentive scheme laid side by side, and the commercial data underneath them. Achievement and payout are calculated from governed commercial data, so a rep sees the same figure that their manager and finance see.
When is it not the right fit?
It is not the right fit if you want clawbacks or penalty framing as a lever, because the evidence says they do not durably work. It is also not the right fit if you want a scheme structured as an inducement to a healthcare professional, which the SA Marketing Code prohibits. If the commercial data underneath cannot be trusted, the foundation comes first, and our Commercial Data Management service builds and governs it.
Frequently asked questions
How do you set a target a pharma rep will chase?
We build each territory's target bottom-up from what its accounts actually buy and prescribe, using real transaction history, not last year plus a percentage.
Do you design the incentive scheme or also run it?
Both. We design the targets, the payment curve and the incentive policy as one system, then operate and run the scheme live every week.
What do your schemes reward?
They are quota-based and conditional, segmented by performer tier where the design calls for it, with deliberate reward timing. They reward internal rep behaviour and are never structured as an inducement to a healthcare professional, which the SA Marketing Code prohibits.
What evidence supports quota-based conditional incentives?
A published field experiment on sales-force pay, Incentives versus Reciprocity in the Journal of Marketing Research, found that quota-based conditional incentives lifted sales by about 24 percent across every performer tier. That is a published result, not a Herbst result.
Can you fix an incentive scheme that has stopped motivating the team?
Yes. We diagnose where the scheme has broken the link between effort and reward, rebuild fair targets from territory reality, and run the corrected scheme live. In one anonymised engagement where five reps had effectively disengaged, a mid-year restructure brought three of them back to within 15 percent of a fair, rebuilt target and two posted their strongest fourth quarter in years.